On April 21, 2025, a specialized symposium titled “Oncolytic Virus Engineering for Cancer Treatment” was held by the Iranian Immunology and Allergy Association in collaboration with the Iranian Cancer Institute Association at the Conference Hall of Hazrat Mahdi Hospital, Imam Khomeini Hospital Complex. The event aimed to explore the application of oncolytic viruses in cancer treatment and facilitate the exchange of scientific findings among specialists and researchers in this field.
Taskeen Regenerative Biotechnology, as one of the main sponsors of the symposium, played a key role in ensuring the success of this event. The company’s support highlights its commitment to scientific advancements in cancer treatment, particularly in the field of oncolytic viruses.
This symposium provided an excellent opportunity for sharing the latest scientific achievements and strengthening collaborations in the development of innovative cancer therapies.